Table 2.
CRISPR-Cas9 systems for genome editing in non-conventional yeasts.
| Yeast | Cas9 expression | sgRNA expression | Gene disruption rate | HR rate | Reference |
|---|---|---|---|---|---|
| K. lactis | ScFBA1 promoter Genome integrated |
SNR52 promoter | N/A | 2% (3 integrations simultaneously) in NHEJ deficient strain | [35] |
| K. marxianus | ScTEF1 promoter codon-optimized |
RPR1′-tRNAGly | 66% | N/A | [62] |
| S. stipitis | eno1 promoter codon-optimized |
SNR52 promoter | 80% | N/A | [27] |
| Y. lipolytica | TEFintron promoter codon-optimized |
TEFintron promoter, flanked by hammerhead and hepatitis delta virus ribozymes | 85% | 11% in wildtype up to 100% in NHEJ deficient strain |
[60] |
| Y. lipolytica | UAS1B8-TEF promoter codon-optimized |
SCR1′-tRNAGly promoter | 92% | 64% in wildtype up to 100% in NHEJ deficient strain |
[61] |
| H. polymorpha | DH3 promoter human codon-optimized |
tRNALeu | 71% | 47% (marker integration with selection) | [64] |
| P. pastoris | HTX1 promoter human codon-optimized |
HTX1 promoter, flanked by hammerhead and hepatitis delta virus | 100% | 20% | [63] |